NIH-funded research NIH-funded research

Understanding how brain resilience and multiple brain pathologies influence aging and Alzheimer's disease

Official title: Epidemiologic Study of Neural Reserve and Neurobiology of Aging

Funded at Rush University Medical Center · NIH-11616280 · Data updated 2026-11-12

A long-term study follows older adults to learn how resilience to brain changes helps reduce dementia risk and what biological factors are linked to better cognitive aging.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRush University Medical Center
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 30, 2001
Project endAugust 31, 2027
Funding year2026
Award (this year)$2,628,894
NIH project number2R56AG017917-21A1
Project IDNIH-11616280 on NIH RePORTER

Who could benefit from this research

Could help

Adults aged 65 and older who participate in the Rush MAP cohort and are willing to contribute clinical and brain data, with consent for autopsy or post-mortem analyses where applicable.

Less likely to help

Participants without the specific brain-pathology combinations studied or those not experiencing cognitive decline may see no direct benefit.

What this research studies

The Rush Memory and Aging Project tracks participants over time, examining many brain pathologies and their combined effects on cognitive decline. Researchers look beyond classic Alzheimer’s pathology to identify non-genomic risk factors and molecular clues that contribute to resilience against dementia. The study uses brain autopsies, cognitive assessments, and molecular data to map how different pathways relate to aging and cognitive health, with an eye toward therapies that boost resilience. Results could point to new targets, like druggable proteins, to help people maintain thinking skills even if brain changes occur.

Why it matters

Potential benefit: Findings could lead to new strategies that strengthen brain resilience and protect thinking abilities in older adults.

How similar studies have gone: Previous work has linked resilience factors and multi-omic signals to cognitive aging, with promising directions for therapy, but translating to clinical treatments remains ongoing.

Where this research is happening

  • Rush University Medical Center
    Chicago, United States
    Active

Researchers

  • Principal investigator: Bennett, David Alan — Rush University Medical Center
  • Study coordinator: Bennett, David Alan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.